ArticleJCO clinical cancer informatics2025

Development of a Machine Learning Model for Aspyre Lung Blood: A New Assay for Rapid Detection of Actionable Variants From Plasma in Patients With Non-Small Cell Lung Cancer.

Rebecca N Palmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.